C07K 14/43531
From mites
Official title: {from mites}
C07K14/43531 (From mites) appears on 118 US grants and 129 published applications in this corpus.
Search patents in C07K- Granted patents
- 118
- Published applications
- 129
- Assignees
- 86
- Inventors
- 219
- Latest grant
- 26 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 6 | 0 |
| 1999 | 5 | 0 |
| 2000 | 8 | 0 |
| 2001 | 5 | 0 |
| 2002 | 3 | 4 |
| 2003 | 2 | 4 |
| 2004 | 4 | 4 |
| 2005 | 2 | 6 |
| 2006 | 3 | 7 |
| 2007 | 5 | 9 |
| 2008 | 2 | 8 |
| 2009 | 3 | 6 |
| 2010 | 7 | 10 |
| 2011 | 5 | 7 |
| 2012 | 2 | 4 |
| 2013 | 5 | 7 |
| 2014 | 5 | 8 |
| 2015 | 4 | 7 |
| 2016 | 5 | 6 |
| 2017 | 4 | 6 |
| 2018 | 4 | 5 |
| 2019 | 3 | 5 |
| 2020 | 2 | 5 |
| 2021 | 4 | 8 |
| 2022 | 8 | 2 |
| 2023 | 2 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Lamp constructs comprising allergens26 Aug 2025US 12,398,195 B2Immunomic Therapeutics, Inc.
- Treatment and prevention of house dust mite allergies3 Oct 2023US 11,771,760 B2Worg Pharmaceuticals (Zhejiang) Co., Ltd.
- Immunogenic peptides and their use in immune disorders8 Aug 2023US 11,718,650 B2Imcyse SA
- Cleavable peptides and insecticidal and nematicidal proteins comprising same27 Dec 2022US 11,535,653 B2Vestaron Corporation
- Cleavable peptides and insecticidal and nematicidal proteins comprising same20 Sep 2022US 11,447,531 B2Vestaron Corporation
- Immunogenic peptides and their use in immune disorders1 Feb 2024US 2024/0034759 A1Imcyse SA
- Cleavable peptides and insecticidal and nematicidal proteins comprising same1 Dec 2022US 2022/0380417 A1Vestaron Corporation
- Modulation of antigen immunogenicity by addition of epitopes recognized by nkt cells18 Aug 2022US 2022/0259262 A1Imnate Sarl
- Modulation of antigen immunogenicity by deleting epitopes recognized by nkt cells18 Nov 2021US 2021/0355162 A1Imnate Sarl
- Nucleic acid for treating mite allergy4 Nov 2021US 2021/0340549 A1Astellas Pharma Inc.
Most cited
By later US patents
- Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions98US 5,266,317 AUniversity of Georgia Research Foundation, Inc. · 1993
- Cloning and sequencing of allergens of dermatophagoides (house dust mite)31US 5,433,948 A1995
- Cloning of mite allergens31US 6,132,734 AImmuLogic Pharmaceuticals, Inc. · 2000
- Allergen peptide fragments and use thereof31US 8,075,897 B2Anergis S.A. · 2011
- Recombinant 40 KDa Dermatophagoides farinae allergen28US 5,314,991 AFumakilla Limited · 1994